Disease associations

Byserotype

Byallele

Nomenclature

Common haplotype

Interactions

References

1. ^^abcENSG00000233841, ENSG00000228299, ENSG00000225691, ENSG00000206435, ENSG00000237022, ENSG00000206452 GRCh38: Ensembl release 89: ENSG00000204525, ENSG00000233841, ENSG00000228299, ENSG00000225691, ENSG00000206435, ENSG00000237022, ENSG00000206452 –Ensembl, May 2017
2. ^"Human PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
3. ^Ríos A, Rodríguez JM, Moya MR, Galindo PJ, Canteras M, Alvarez MR, Parrilla P (2006)."Associations of HLA-C alleles with multinodular goiters: study in a population from southeastern Spain".Arch Surg.141 (2):123–8.doi:10.1001/archsurg.141.2.123.PMID 16490887.
4. ^Montes-Ares O, Moya-Quiles MR, Montes-Casado M, Guerra-Pérez N, Campillo JA, González C, López-Bermejo A, Tamayo M, Majado MJ, Parrado A, Muro M, Marín L, Alvarez-López MR (2006). "Human leucocyte antigen-C in B chronic lymphocytic leukaemia".Br J Haematol.135 (4):517–9.doi:10.1111/j.1365-2141.2006.06334.x.PMID 17054674.S2CID 23018830.
5. ^Boyson JE, Erskine R, Whitman MC, Chiu M, Lau JM, Koopman LA, Valter MM, Angelisova P, Horejsi V, Strominger JL (December 2002)."Disulfide bond-mediated dimerization of HLA-G on the cell surface".Proc. Natl. Acad. Sci. U.S.A.99 (25):16180–5.Bibcode:2002PNAS...9916180B.doi:10.1073/pnas.212643199.PMC 138585.PMID 12454284.
6. ^Baba E, Erskine R, Boyson JE, Cohen GB, Davis DM, Malik P, Mandelboim O, Reyburn HT, Strominger JL (December 2000). "N-linked carbohydrate on human leukocyte antigen-C and recognition by natural killer cell inhibitory receptors".Hum. Immunol.61 (12):1202–18.doi:10.1016/s0198-8859(00)00184-1.PMID 11163076.
7. ^Valés-Gómez M, Reyburn HT, Mandelboim M, Strominger JL (September 1998)."Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors".Immunity.9 (3):337–44.doi:10.1016/s1074-7613(00)80616-0.PMID 9768753.
8. ^Fan QR, Long EO, Wiley DC (May 2001). "Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex".Nat. Immunol.2 (5):452–60.doi:10.1038/87766.PMID 11323700.S2CID 24707532.
9. ^Jones DC, Kosmoliaptsis V, Apps R, Lapaque N, Smith I, Kono A, Chang C, Boyle LH, Taylor CJ, Trowsdale J, Allen RL (March 2011)."HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding".J. Immunol.186 (5):2990–7.doi:10.4049/jimmunol.1003078.PMID 21270408.

Further reading

• Geyer M, Fackler OT, Peterlin BM (2001)."Structure--function relationships in HIV-1 Nef".EMBO Rep.2 (7):580–5.doi:10.1093/embo-reports/kve141.PMC 1083955.PMID 11463741.
• Greenway AL, Holloway G, McPhee DA, Ellis P, Cornall A, Lidman M (2004). "HIV-1 Nef control of cell signalling molecules: multiple strategies to promote virus replication".J. Biosci.28 (3):323–35.doi:10.1007/BF02970151.PMID 12734410.S2CID 33749514.
• Bénichou S, Benmerah A (2003)."[The HIV nef and the Kaposi-sarcoma-associated virus K3/K5 proteins: "parasites"of the endocytosis pathway]".Med Sci (Paris).19 (1):100–6.doi:10.1051/medsci/2003191100.PMID 12836198.
• Leavitt SA, SchOn A, Klein JC, Manjappara U, Chaiken IM, Freire E (2004). "Interactions of HIV-1 proteins gp120 and Nef with cellular partners define a novel allosteric paradigm".Curr. Protein Pept. Sci.5 (1):1–8.doi:10.2174/1389203043486955.PMID 14965316.
• Tolstrup M, Ostergaard L, Laursen AL, Pedersen SF, Duch M (2004). "HIV/SIV escape from immune surveillance: focus on Nef".Curr. HIV Res.2 (2):141–51.doi:10.2174/1570162043484924.PMID 15078178.
• Joseph AM, Kumar M, Mitra D (2005). "Nef: "necessary and enforcing factor" in HIV infection".Curr. HIV Res.3 (1):87–94.doi:10.2174/1570162052773013.PMID 15638726.
• Anderson JL, Hope TJ (2005). "HIV accessory proteins and surviving the host cell".Current HIV/AIDS Reports.1 (1):47–53.doi:10.1007/s11904-004-0007-x.PMID 16091223.S2CID 34731265.

External links